Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

FDA approves new dosing regimen for SB's amoxicillin

July 27, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

FDA approves new dose range for Zocor

July 23, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...